Pharma Stocks Tumble as Trump Targets U.S. Drug Prices

shares plunged as much as 6.93% in morning trade on May 12, 2025, dragging the Nifty Pharma index down over 2.3%. The sell-off came after former U.S. President Donald Trump announced plans to sign an executive order aimed at slashing prescription drug prices by 30% to 80%, citing that medicine costs in the U.S. remain "unacceptably high." The move sparked fears of margin pressure on Indian pharmaceutical exporters heavily reliant on the U.S. market. Traders are closely watching for further details on the order and its implementation impact. Disclaimer: This post is for informational purposes only and does not constitute investment advice.